Patients with atrial fibrillation may be less likely to have recurring symptoms following ablation treatment with force-sending catheters from Johnson & Johnson subsidiary Biosense Webster, researchers say.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/P1qnnF
Cap comentari:
Publica un comentari a l'entrada